ZURA compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

ZURAZura Bio Ltd

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

ZURAZura Bio Ltd

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

ZURAZura Bio Ltd

3.83▼−4.73%

Mkt cap$513.4MRevenue—Revenue—

AMGNAmgen Inc

468.57▼−2.07%

Regular sessionNov 5 '26

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

Regular sessionNov 5 '26

ZURAZura Bio Ltd

AMGNAmgen Inc

3.83▼−4.73%

Price

468.57▼−2.07%

$513.4M

Mkt cap

$258.8B

—

Revenue

$10.4BQ3 FY26

—

Revenue

$36.8BFY25

ZURA3.83▼−4.73%vsAMGN468.57▼−2.07%Regular sessionNov 5 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

ZURA: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ZURA 2

LLYEli Lillysupplier

PFEPfizersupplier

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customerSource: SEC EDGAR

8 more · AMGN chain ›

Price

rebased to 0%

ZURA, solidAMGN, dashed